Form 4: Oncology Institute Chief Administrative Officer Receives Significant Stock Grant

Kristin England, Chief Administrative Officer of Oncology Institute, Inc., acquired 98,037 shares of common stock through a fully vested Restricted Stock Unit (RSU) award.

Summary

• Kristin England, the Chief Administrative Officer of Oncology Institute, Inc. (TOI), reported the acquisition of 98,037 shares of common stock.
• The transaction occurred on July 22, 2025, and involved the acquisition of shares at a price of $0 per share.
• The shares represent Restricted Stock Unit (RSU) awards that were fully vested upon grant, net of withholding tax obligations.
• Following this transaction, Kristin England directly beneficially owns 98,037 shares of Oncology Institute, Inc. common stock.

Sentiment

Score: 7

Explanation: The grant of fully vested Restricted Stock Units to a key executive is a positive indicator of management alignment and retention strategy, though it is a routine compensation disclosure rather than a performance-related announcement.

Positives

• The grant of fully vested Restricted Stock Units to a key executive like the Chief Administrative Officer indicates strong alignment of management interests with shareholder value.
• The immediate vesting of the RSU awards upon grant provides the executive with immediate ownership, serving as a direct incentive.

Industry Context

This filing details a routine executive compensation event, specifically the grant of Restricted Stock Units, which is a common practice across various industries, including healthcare, to incentivize and retain key management personnel by aligning their interests with the company's long-term performance.

Related Party Transactions

• The acquisition of 98,037 shares by Kristin England, a Chief Administrative Officer, represents a related party transaction in the form of an RSU award from Oncology Institute, Inc. as part of her compensation package.

Stakeholder Impact

• Shareholders: The RSU grant aligns the executive's financial interests with the company's stock performance, potentially benefiting shareholders through improved long-term decision-making.
• Employees: This type of executive compensation can signal stability and a commitment to retaining key talent within the company.

Key Dates

Keywords

Oncology Institute, TOI, Kristin England, Chief Administrative Officer, Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Stock Grant